{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:01:10Z","timestamp":1765609270928},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T00:00:00Z","timestamp":1118275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T00:00:00Z","timestamp":1118275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>The role of Prostate Specific Antigen (PSA) testing in the early detection of prostate cancer is controversial. Current UK policy stipulates that any man who wishes to have a PSA test should have access to the test, provided he has been given full information about the benefits and limitations of testing. This study aimed to determine UK GPs' current reported practice regarding PSA testing, and their views towards informed decision-making and PSA testing.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Method<\/jats:title>\n                        <jats:p>Online questionnaire survey, with a sample of 421 GPs randomly selected from a database of GPs across the UK.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>95% (400\/421) of GPs responded. 76% of GPs reported having performed a PSA test for an asymptomatic man at least once in the previous three months, with 13% reported having tested more than five men in this period. A majority of GPs reported they would do a PSA test for men presenting with a family history and requesting a test, for asymptomatic men requesting a test and also for men presenting with lower urinary tract symptoms. Reported testing rates were highest for men with a family history. Amongst men with lower urinary tract symptoms and men with no symptoms, reported testing rates were significantly higher for older than younger men.<\/jats:p>\n                        <jats:p>The majority of GPs expressed support for the current policy (67%), and favoured both the general practitioner and the man being involved in the decision making process (83%). 90% of GPs indicated that they would discuss the benefits and limitation of testing with the man, with most (61%) preferring to ask the man to make a further appointment if he decides to be tested.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>This study indicates that PSA testing in asymptomatic men is a regular occurrence in the UK, and that there is general support from GPs for the current policy of making PSA tests available to 'informed' men who are concerned about prostate cancer. While most GPs indicated they would discuss the benefits and limitations prior to PSA testing, and most GPs favoured a shared approach to decision making, it is not known to what extent men are actually being informed. Research is needed to evaluate the most effective approach to assisting men in making an informed decision about whether or not to have a PSA test.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2296-6-24","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T18:13:42Z","timestamp":1118340822000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK"],"prefix":"10.1186","volume":"6","author":[{"given":"Jo","family":"Brett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eila","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Hewitson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Bukach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glyn","family":"Elwyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Austoker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,6,9]]},"reference":[{"key":"103_CR1","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199511233332107","volume":"333","author":"SH Woolf","year":"1995","unstructured":"Woolf SH: Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med. 1995, 333: 1401-1405. 10.1056\/NEJM199511233332107.","journal-title":"N Engl J Med"},{"key":"103_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1046\/j.1464-4096.2001.02449.x","volume":"88","author":"FH Schroder","year":"2001","unstructured":"Schroder FH, Wildhagen MF: Screening for prostate cancer: evidence and perspectives. BJU Int. 2001, 88: 811-817. 10.1046\/j.1464-4096.2001.02449.x.","journal-title":"BJU Int"},{"key":"103_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1470-2045(00)00005-X","volume":"1","author":"DE Neal","year":"2000","unstructured":"Neal DE, Donovan JL: Prostate cancer: to screen or not to screen?. Lancet Oncology. 2000, 1: 17-24. 10.1016\/S1470-2045(00)00005-X.","journal-title":"Lancet Oncology"},{"key":"103_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ijc.1588","volume":"97","author":"HJ de Koning","year":"2002","unstructured":"de Koning HJ, Auvinen A, Berenguer-Sanchez A, Calais-Da-Silva F, Ciatto S, Denis L, Gohajen JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schroder FH: Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer. 2002, 97: 237-244. 10.1002\/ijc.1588.","journal-title":"Int J Cancer"},{"key":"103_CR5","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1835::AID-CNCR23>3.0.CO;2-5","volume":"80","author":"CR Smart","year":"1997","unstructured":"Smart CR: The results of prostate carcinoma screening in the US as reflected in the Surveillance, Epidemiology and End Results Program. Cancer. 1997, 80: 1835-10.1002\/(SICI)1097-0142(19971101)80:9<1835::AID-CNCR23>3.0.CO;2-5.","journal-title":"Cancer"},{"key":"103_CR6","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(00)02269-8","volume":"355","author":"SE Oliver","year":"2000","unstructured":"Oliver SE, Gunnell D, Donovan JL: Comparison of trends in prostate cancer mortality in England and Wales and the USA. Lancet. 2000, 355: 1788-1789. 10.1016\/S0140-6736(00)02269-8.","journal-title":"Lancet"},{"key":"103_CR7","volume-title":"The NHS Prostate Cancer Programme","author":"NHS Executive","year":"2000","unstructured":"NHS Executive: The NHS Prostate Cancer Programme. 2000"},{"key":"103_CR8","volume-title":"Programme","author":"UK.National Screening Committee","year":"2001","unstructured":"UK.National Screening Committee: Prostate Cancer Risk Management. Programme. 2001, [http:\/\/www.cancerscreening.nhs.uk\/prostate\/index.html]"},{"issue":"3","key":"103_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jms.9.3.109","volume":"9","author":"J Melia","year":"2002","unstructured":"Melia J, Moss S, Johns L: Rates of Prostate Specific Antigen testing in general practice in England and Wales in asymptomatic and symptomatic men: a cross-sectional study. J Med Screen. 2002, 9 (3): 109-114. 10.1136\/jms.9.3.109.","journal-title":"J Med Screen"},{"key":"103_CR10","first-page":"1","volume":"116","author":"J Durham","year":"2003","unstructured":"Durham J, Low M, McLeod D: Screening for prostate cancer: a survey of New Zealand general practitioners. New Zealand Medical Journal. 2003, 116: 1-9.","journal-title":"New Zealand Medical Journal"},{"key":"103_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1467-842X.1998.tb01394.x","volume":"22","author":"J Ward","year":"1998","unstructured":"Ward J, Young J, Sladden M: Australian general practitioners' views and use of tests to detect early protate cancer. Australian and New Zealand Journal of Public Health. 1998, 22: 374-380.","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"103_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0002-9343(98)00124-7","volume":"104","author":"FJ Fowler","year":"1998","unstructured":"Fowler FJ, Bin L, McNaughton Collins M, Roberts RG, Oesterling JE, Wasson JH, Barry MJ: Prostate cancer screening and beliefs about treatment efficacy: A national survey of Primary Care Physicians and Urologists. American Journal of Medicine. 1998, 104: 526-532. 10.1016\/S0002-9343(98)00124-7.","journal-title":"American Journal of Medicine"},{"key":"103_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0090-4295(01)01504-7","volume":"59","author":"HJ Kim","year":"2002","unstructured":"Kim HJ, Benson DA, Stern SD, Gerber GS: Practice trends in the management of prostate disease by family practice physicians and general internists: an internet based survey. Adult Urology. 2002, 59: 266-267.","journal-title":"Adult Urology"},{"key":"103_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0272989X03256010","volume":"Jul-Aug","author":"PC Sorum","year":"2003","unstructured":"Sorum PC, Shim J, Chasseigne G, Bonnin-Scaon S, Cogneau J, Mullet E: Why do primary care physicians in the United States and France order prostate specific antigen tests for asymptomatic patients?. Medical Decision Making. 2003, Jul-Aug: 301-313. 10.1177\/0272989X03256010.","journal-title":"Medical Decision Making"},{"key":"103_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/jms.7.2.116","volume":"7","author":"GS Kalsi","year":"2000","unstructured":"Kalsi GS, Rajaratnam G, Bridgman SA: Primary care perspective of prostate cancer screening after national guidance: a questionnaire survey. J Med Screen. 2000, 7: 116-716. 10.1136\/jms.7.2.116.","journal-title":"J Med Screen"},{"issue":"3","key":"103_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/fampra\/cmg311","volume":"20","author":"M Gattellari","year":"2003","unstructured":"Gattellari M, Young JM, Ward JE: GP and patient predictors of PSA screening in Australian general practice. Family Practice. 2003, 20 (3): 294-33. 10.1093\/fampra\/cmg311.","journal-title":"Family Practice"},{"key":"103_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1464-410x.1999.00905.x","volume":"83","author":"DP Dearnaley","year":"1999","unstructured":"Dearnaley DP, Kirby RS, Kirk D, Malone P, Simpson RJ, Williams G: Diagnosis and management if early prostate cancer. Report of a British Association of Urological Surgeons Working Party. BJU International. 1999, 83: 18-33. 10.1046\/j.1464-410x.1999.00905.x.","journal-title":"BJU International"},{"key":"103_CR18","first-page":"617","volume":"54","author":"W Hamilton","year":"2004","unstructured":"Hamilton W, Sharp D: Symptomatic diagnosis of prostate cancer in primary care: a structured review. British Journal of General Practice. 2004, 54: 617-621.","journal-title":"British Journal of General Practice"},{"key":"103_CR19","volume-title":"NHS Cancer Screening Programmes, Sheffield","author":"E Watson","year":"2002","unstructured":"Watson E, Jenkins L, Bukach C, Brett J, Austoker J: PSA testing for prostate cancer:an information pack for primary health care teams. NHS Cancer Screening Programmes, Sheffield. 2002"},{"key":"103_CR20","first-page":"178","volume":"110","author":"J Morris","year":"1997","unstructured":"Morris J, McNoe B, Adam H: Screening for prostate cancer: what do general practictioners think?. NZ Med J. 1997, 110: 178-82.","journal-title":"NZ Med J"},{"key":"103_CR21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5694\/j.1326-5377.1995.tb139968.x","volume":"162","author":"MJ Sladden","year":"1995","unstructured":"Sladden MJ, Dickinson JA: General practitioners' attitudes to screening for prostate and testicular cancers. Med J Austr. 1995, 162: 410-413.","journal-title":"Med J Austr"},{"issue":"1","key":"103_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3322\/canjclin.50.1.34","volume":"50","author":"RA Smith","year":"2000","unstructured":"Smith RA, Mettlin CJ, Davis KJ, Eyre H: American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2000, 50 (1): 34-49.","journal-title":"CA Cancer J Clin"},{"key":"103_CR23","volume-title":"Screening for prostate cancer: recommendations and rationale","author":"US Preventive Services Task Force","year":"2002","unstructured":"US Preventive Services Task Force: Screening for prostate cancer: recommendations and rationale. 2002, [http:\/\/www.ahrq.gov\/clinic\/3rduspstf\/prostatescre\/prostaterr.pdf]"},{"key":"103_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jms.9.3.109","volume":"9","author":"E Dormandy","year":"2002","unstructured":"Dormandy E, Hooper R, Michie S, Marteau TM: Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. J Med Screening. 2002, 9: 109-114. 10.1136\/jms.9.3.109.","journal-title":"J Med Screening"},{"key":"103_CR25","first-page":"626","volume":"55","author":"ES Tambor","year":"1994","unstructured":"Tambor ES, Bernhardt BA, Chase GA, Faden RR, Geller G, Hofman KJ, Holtzman NA: Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilisation. Am J Hum Genet. 1994, 55: 626-637.","journal-title":"Am J Hum Genet"},{"key":"103_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/fampra\/cmg509","volume":"20","author":"D Braithwaite","year":"2002","unstructured":"Braithwaite D, Sutton S, Smithson WH, Emery J: Internet-based assessment and decision support for the management for familial cancer in primary care: a survey of GP's attitudes and intentions. Family Practice. 2002, 20: 545-549. 10.1093\/fampra\/cmg509.","journal-title":"Family Practice"},{"key":"103_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/fampra\/cmg509","volume":"20","author":"D Braithwaite","year":"2003","unstructured":"Braithwaite D, Emery J, de Lusignan S, Sutton S: Using the Internet to conduct surveys of health professionals: a valid alternative?. Family Practice. 2003, 20: 545-551. 10.1093\/fampra\/cmg509.","journal-title":"Family Practice"},{"key":"103_CR28","volume-title":"Department of Health","author":"Department of Health","year":"2004","unstructured":"Department of Health: Statistics for general medical practitioners in England and Wales. Department of Health. 2004"},{"key":"103_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1054\/bjoc.2001.1962","volume":"85","author":"J Melia","year":"2001","unstructured":"Melia J, Moss S: Survey of the rate of PSA testing in general practice. British Journal of Cancer. 2001, 85 (): 656-657. 10.1054\/bjoc.2001.1962.","journal-title":"British Journal of Cancer"},{"key":"103_CR30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","volume":"342","author":"JM Grimshaw","year":"1993","unstructured":"Grimshaw JM, Russell IT: Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993, 342: 1317-22. 10.1016\/0140-6736(93)92244-N.","journal-title":"Lancet"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-6-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2296-6-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-6-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-6-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:36:51Z","timestamp":1728304611000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/1471-2296-6-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1186\/1471-2296-6-24","relation":{},"ISSN":["1471-2296"],"issn-type":[{"type":"electronic","value":"1471-2296"}],"subject":[],"published":{"date-parts":[[2005,6,9]]},"assertion":[{"value":"29 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}